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ABSTRACT
The convergently transcribed restriction (R)
and methylase (M) genes of the Restriction–
Modification system Esp1396I are tightly regulated
by a controller (C) protein that forms part of the CR
operon. We have mapped the transcriptional start
sites from each promoter and examined the regula-
tory role of C.Esp1396I in vivo and in vitro. C-protein
binding at the CR and M promoters was analyzed
by DNA footprinting and a range of biophysical tech-
niques. The distal and proximal C-protein bind-
ing sites at the CR promoter are responsible for
activation and repression, respectively. In contrast,
a C-protein dimer binds to a single site at the
M-promoter to repress the gene, with an affinity
much greater than for the CR promoter. Thus,
during establishment of the system in a naı ¨ve host,
the activity of the M promoter is turned off early,
preventing excessive synthesis of methylase.
Mutational analysis of promoter binding sites
reveals that the tetranucleotide inverted repeats
long believed to be important for C-protein bind-
ing to DNA are less significant than previously
thought. Instead, symmetry-related elements out-
side of these repeats appear to be critical for
the interaction and are discussed in terms of the
recent crystal structure of C.Esp139I bound to the
CR promoter.
INTRODUCTION
Restriction–modiﬁcation (R–M) systems encode a
restriction endonuclease and a DNA methyltransferase
(methylase). The methylase protects the bacterial host
DNA from cleavage by the associated endonuclease by
methylation of the cognate DNA recognition sequence.
Bacterial cells carrying R–M genes become resistant to
infection by bacteriophages with unmethylated (unmodi-
ﬁed) DNA and thus gain a selective advantage over bac-
teria of the same species but lacking R–M genes. Thus,
R–M genes frequently spread through horizontal transfer
on broad host range plasmids (1,2). R–M systems can also
be considered as ‘addictive’ modules that are impossible to
eliminate because the protective methylase is less stable
than the toxic restriction endonuclease (2,3). Plasmids
containing R–M systems can be readily transformed
into cells containing unmodiﬁed DNA, suggesting
that suﬃcient amounts of methylase are produced to com-
pletely methylate host DNA before the endonuclease
activity appears. Thus, R–M systems must have evolved
mechanisms of coordinate expression of their genes to
minimize potentially fatal consequences to the host
bacterium.
Many type II R–M systems rely on specialized
Controller (C) proteins for coordinated expression of
their genes (4–10). All C-proteins are related through
common ancestry and contain a DNA binding helix–
turn–helix motif (11). The structures of two C-proteins
that have been studied by crystallography revealed that
these proteins form dimers and that each monomer is
similar to the DNA-binding domain of the  repressor
(12,13), although there are important diﬀerences at the
dimer interface that determine the strength of dimeri-
zation, which is crucial to the timing of the genetic
switch (14,15).
Genes coding for C-proteins are almost invariably
located upstream of, and partially overlap with the
endonuclease gene (7–9), forming a single operon. Two
C-protein binding sites are located upstream of and
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When a C-protein dimer binds to the high-aﬃnity
promoter–distal site, transcription is activated leading
to increased C-protein and endonuclease gene expression.
Binding to the weaker promoter–proximal site inhibits
transcription (7,14,17). C-proteins were also shown to
inhibit expression of methylases in some R–M systems
(8,18).
The regulation of R–M gene expression depends on the
relative positions of genes in the system. In C-protein-
dependent R–M systems with divergent organization of
CR and M genes, such as the EcoRV system, interaction
of the C-protein with the high-aﬃnity distal (with respect
to CR promoter) site decreases transcription from the
M promoter due to direct interference from the bound
C-protein (7). In the C-protein-dependent R–M system
AhdI, the M and the CR operons are transcribed con-
vergently (14,17). The ahdI CR operon expression is
regulated by C-protein in a manner generally analogous
to that observed in the case of EcoRV CR operon
regulation. However, M gene expression is C-protein-inde-
pendent and is instead regulated by the AhdI methylase,
which methylates an AhdI site embedded in the  10 ele-
ment of the M promoter leading to decreased transcrip-
tion (17).
The object of this study, C-protein-dependent R–M
system Esp1396I, contains convergent M and CR genes
but with no Esp1396I restriction sites in front of the M
gene. Nevertheless, in vivo analysis revealed that
esp1396IM expression is inhibited by C.Esp1396I (8).
Sequence analysis suggested the presence of tetranucleo-
tide inverted repeats in front of the esp1396ICR operon
(two sets of repeats) and the esp1396IM gene (one set of
perfect repeats and another putative set that contained
several substitutions) (9). The repeats matched well with
C-protein binding sites from several other C-protein-
dependent R–M systems and very recently the
esp1396ICR operon repeats were shown to indeed interact
with C.Esp1396I (19). However, the overall role of
C.Esp1396I binding sites locations in diﬀerential regula-
tion of the esp1396ICR operon and esp1396IM gene
expression has not yet been investigated. Moreover, the
result of the structural analysis suggests that elements of
the binding site distinct from tetranucleotide repeat per se
contribute signiﬁcantly to C.Esp1396I binding. These
elements, such as a conserved TATA spacer between
the repeats and inverted dinucleotides ﬂanking the
site upstream of the esp1396ICR operon, are missing
in one of the putative binding sites upstream of
esp1396IM, raising a question about its signiﬁcance.
Here, we determine transcription initiation start points
of both esp1396I transcription units, show that there is
only one C-protein binding site in front of esp1396IM,
analyze C.Esp1396I interactions with DNA operator
sequences, discuss the regulatory consequences of these
interactions in vivo and in vitro, and derive a plausible
scenario of transcription regulation of the esp1396I
genes. In addition, we test the importance of the elements
of protein–DNA recognition indicated by the crystal
structure of the complex (19).
MATERIALS AND METHODS
Bacteria strains, phages and media
Escherichia coli HB101 and XL1-Blue were used as host
strains in experiments to study the esp1396I genes expres-
sion and vir phage resistance. Phage vir was propagated
as described (20). Cells were grown in LB medium
(1% bactotryptone, 1% NaCl, 0.5% yeast extract, with
or without 1.5% bactoagar) supplemented with appropri-
ate antibiotics. To test for esp1396I genes expression
in vivo, McConkey agar base plates containing 1% galac-
tose were used.
Plasmids and proteins
Plasmid pEsp1396IRM5.6 (8) carrying the entire
Esp1396I R–M system was used as a template for PCR
ampliﬁcation of DNA fragments used for cloning, muta-
genesis and in vitro transcription. Plasmids pEspMet and
pEspRes are derivatives of the pFD51 plasmid (21) with
the galactokinase gene (galK) under the control of the
esp1396IM and esp1396ICR promoters, respectively.
Plasmid pEspMet contains a 101-bp PCR-ampliﬁed
esp1396IM fragment ( 74 to +27 with respect to the
transcription start point at +1); pEspRes contains a
103-bp esp1396IR fragment ( 70 to +33 with respect to
the transcription start). Plasmid pCesp184 was created by
cloning a 347-bp PCR fragment containing the esp1396IC
gene and the esp1396ICR promoter between the NcoI and
EcoRI sites of plasmid pACYC184.
Hexahistidine-tagged C.Esp1396I (C.Esp1396I-6His)
and C.Esp1396I without hexahistidine tag were puriﬁed
as described (19). The protein concentration was deter-
mined using the Bradford method with BSA as a standard.
For analytical ultracentrifugation experiments, UV
absorption spectroscopy was used to measure the pro-
tein concentration, taking the theoretical extinction
coeﬃcient e276=2900M
 1cm
 1. Throughout the text,
molar concentration of C.Esp1396I refers to monomer
concentration.
Escherichia coli RNAP s
70 holoenzyme was puriﬁed as
described (22).
Primer extension reactions
HB101 cells harboring the pEspMet and pEspRes plas-
mids with or without compatible pCesp184 plasmid were
grown to OD600=0.4 and total RNA was extracted using
RNeasy Mini Kit (Qiagen) according to the manufac-
turer’s protocol with the inclusion of the DNaseI digestion
step. For a single extension reaction, 10mg of total RNA
were reverse-transcribed with 100U of SuperScript III
enzyme of First-Strand Synthesis Kit for RT–PCR
(Invitrogen) according to the manufacturer’s protocol in
the presence of 1pmol of [
32P] 50-end-labeled primers. The
reaction products were treated with RNase H, precipitated
by ethanol and dissolved in a loading buﬀer containing
7M urea–formamide and resolved on 6% sequencing gels.
Sequencing reactions performed with the same end-labeled
primers and pEspMet and pEspRes as a templates using
fmol DNA Cycle Sequencing System (Promega).
Nucleic Acids Research, 2009,Vol.37, No. 10 3355Electrophoretic mobility shift assay
A1 0n M[
32P]-end-labeled DNA fragments containing the
wild-type or mutant C-protein-binding sites were incu-
bated for 10min at 378Ci n1 0 ml reaction buﬀer [40mM
Tris–HCl (pH 8.0) 10mM NaCl, 10mM MgCl2,1 m M
DTT, 5% glycerol] with 0–1024nM of C.Esp1396I-6His
in the presence of 5mg/ml of competitor DNA. Following
the addition of 2ml of loading buﬀer (30% glycerol, 0.05%
bromophenol blue, 10mM EDTA), samples were loaded
onto 8% native polyacrylamide gels. After electrophor-
esis, reaction products were visualized and quantiﬁed
using a PhosphorImager.
Footprinting and in vitro transcription
For in vitro transcription, promoter complexes were
allowed to form for 10min at 378Ci n1 0ml reactions con-
taining 40mM Tris–HCl (pH 8.0) 40mM KCl, 10mM
MgCl2, 1mM DTT, 5% glycerol, 100nM E. coli RNAP
s
70 holoenzyme and 10nM esp1396I DNA fragments.
Where indicated, DNA was incubated with C.Esp1396I-
6His prior to the addition of RNAP. To initiate transcrip-
tion reaction, a mixture of 200mM ATP, CTP and UTP,
20mM GTP and 10mCi of [a-
32P]GTP (3000Ci/mmol)
and heparin (ﬁnal concentration 30mg/ml) was added to
promoter complexes. After incubation at 378C for 15min,
reactions were terminated by the addition of equal volume
of 7M urea–formamide-containing loading buﬀer and
resolved on 8% sequencing gels.
KMnO4 probing and DNase I footprinting were con-
ducted under conditions used for in vitro transcription
using P
32-labeled promoter fragments as described (17).
G+A sequencing reactions were carried out as described
(23). Samples were applied on 6% sequencing gels and
reaction products revealed using a PhosphorImager.
Sedimentation velocity and sedimentation equilibrium
experiments
Sedimentation velocity experiments were performed in
a Beckman XL-A analytical ultracentrifuge equipped
with an An50-Ti rotor using double sector cells of
12mm optical path-length. Sample cells contained 400ml
of C.Esp1396I at 0, 10 and 20mM and Hex-labeled 35-bp
DNA fragments containing the binding sites (5mM). The
reference cells contained 425ml of buﬀer (40mM Tris–HCl
pH 8.0, 100mM NaCl and 5% glycerol). The cells were
loaded and left to equilibrate to 208C. The rotor was accel-
erated to 40000r.p.m. and readings of absorbance versus
radial distance were taken every 12min at 540nm. The raw
data were analyzed with program Sedﬁt (24), using radial
data within the range 6.07–6.93cm for the ﬁrst 75 scans.
Partial speciﬁc volumes for the dimer and tetramer (0.644
and 0.678ml/g, respectively) were calculated using the pro-
gram Sednterp and corrected for temperature (25). For
DNA alone, a value of 0.55ml/g was used corresponding
to tabulated values (26); for dimer and tetramer nucleo-
protein complexes, weight average values were calculated.
Finally, the experimental sedimentation coeﬃcients
obtained from the c(S) distribution plot were corrected
for temperature and solvent to obtain a s20,w value.
Sedimentation equilibrium experiments were performed
using the same centrifuge and rotor as for the velocity
experiments. Six-channel cells of 12mm optical path-
length containing 90ml of solution at protein concentra-
tions ranging from 5 to 64mM were used; 100ml of the
sample buﬀer (40mM Tris–HCl, pH 8.0, 100mM NaCl,
5% glycerol) was loaded into the corresponding channel.
The rotor was accelerated to 15000, 21000 and 28000
r.p.m. and scans of absorbance (275 and 235nm) versus
radial displacement were taken at a resolution of 0.001cm
for times up to 21h. The temperature was set at 208C.
Fluorescence polarization assays
HPLC-puriﬁed ﬂuorescein-labeled oligonucleotides and
their complementary partners were obtained from ITD
(Corralville, IA, USA). The 20ml reaction mixtures (in
40mM Tris–HCl, pH 8.0, 10mM MgCl2, 5% glycerol
and 50mg/ml calf thymus DNA) containing 10nM
ﬂuorescein-labeled DNA and indicated C.Esp1396I pro-
tein concentration were prepared in triplicates and ﬂuo-
rescence polarization was read in 384-well microplates
using Analyst AD reader (Molecular Devices,
Sunnyvale, CA, USA).
Fluorescence polarization data were analyzed using
numerical nonlinear regression with SCIENTIST
(MicroMath, Salt Lake City, UT, USA). Equilibrium
titrations of Pesp1396IM DNA with C.Esp1396I were
ﬁtted to:
pol ¼ pol1
 ½DNA þpol2
 ½P : DNA  1
where, pol is observed ﬂuorescence polarization, pol1
and pol2 are speciﬁc ﬂuorescence polarizations of free
DNA and DNA in complex with the C.Esp1396I protein
dimer (P), respectively. Binding of C.Esp1396I to the
Pesp1396IM DNA is described by two equilibrium con-
stants: protein dimerization constant (Kdim; it was ﬁxed at
600nM during ﬁtting, the value measured by analytical
centrifugation) and dissociation constant of protein
dimer–DNA complex (K). Equilibrium titrations of
Pesp1396ICR DNA with the protein were ﬁtted to:
pol ¼ pol1
 ½DNA þpol2
 ½P : DNAp 
þ pol2
 ½P : DNAd þpol3
 ½P2 : DNA 
2
where, pol is observed ﬂuorescence polarization, pol1,
pol2 and pol3 are speciﬁc ﬂuorescence polarizations of
free DNA, DNA in complex with one C.Esp1396I
dimer, and DNA in complex with two C.Esp1396I
dimers, respectively. P:DNAp and P:DNAd refer to
of C.Esp1396I dimers bound to the proximal and
distal site, respectively. Binding of C.Esp1396I to the
Pesp1396ICR DNA is described by four parameters: pro-
tein dimerization constant (Kdim; ﬁxed at 600nM during
ﬁtting, the value measured by analytical centrifugation),
dissociation constants of C.Esp1396I dimer complexes
with proximal and distal sites (Kp and Kd, respectively)
and a cooperatively constant describing the eﬀect of
C.Esp1396I binding to one site on the aﬃnity of the pro-
tein to the other site (calculated as the ratio of equilibrium
constants for a given site when the other site is bound and
3356 Nucleic Acids Research, 2009, Vol. 37,No. 10free, respectively). During the ﬁt, concentrations of all
species were calculated numerically for each point by sol-
ving the appropriate set of mass conservation equations
deﬁned by a particular model (27). The data for the wild-
type and all of the mutant DNA fragments were ﬁtted
simultaneously to force common parameters between
data sets to be the same.
RESULTS
Mapping transcription start sites in Esp1396I
The genetic organization of Esp1396I is shown in
Figure 1. The esp1396IC and esp1396IR genes partially
overlap and likely form an operon. The esp1396IM gene
is transcribed convergently with respect to the esp1396ICR
gene pair. A putative bidirectional transcription termina-
tors is located in the intergenic region separating the
esp1396ICR genes and the esp1396IM gene.
To better understand the regulation of Esp1396I, we
identiﬁed transcription start points of Esp1396I genes by
performing primer extension reactions with total RNA
prepared from E. coli cells harboring a plasmid containing
complete Esp1396I R–M system (8). This plasmid is stably
maintained in E. coli and cells harboring this plasmid
restrict the growth of phage  (Figure 2A, left panel)
indicating that both Esp1396I methyltransferase and
restriction endonuclease are expressed. We wished to use
RNA from cells harboring an Esp1396I R–M plasmid
containing a lesion in the esp1396IC gene to reveal
C.Esp1396I-dependent transcription start sites. However,
no such plasmid could be constructed, indicating that
intact esp1396IC is necessary for establishment and/or
maintenance of esp1396I genes in the cell. Similar obser-
vations were made previously and were explained by pos-
tulating that expression of the esp1396IM gene in the
absence of C.Esp1396I is toxic to the cell (8). Extension
of primers annealing to various places within the
esp1396ICR genes revealed a single primer extension prod-
uct (Figure 2A, center panel and data not shown),
supporting the notion that the esp1396ICR gene pair is
transcribed from a single promoter (8). The primer exten-
sion product mapped to an adenine located 27-bp
upstream of the initiating ATG codon of esp1396IC.
Thus, unlike several other studied CR transcripts that
were shown to be leaderless (7,17,28), the esp1396ICR
transcript is translated in a conventional way (indeed,
there is a recognizable Shine–Dalgarno sequence at an
appropriate distance from the initiating ATG codon of
esp1396I.C, Figure 1). The esp1396ICR transcription
start site is preceded by a CATTAT sequence that is
appropriately positioned to serve as a  10 promoter ele-
ment (consensus sequence TATAAT). The place where the
 35 promoter element (consensus sequence TTGACA)
C-box
5’nnnTTTAATGTGACTTATAGTCCGTGTGATTATAGTCAACATGAAGGCATTATTGACCTATCAACA 3’
3’nnnAAATTACACTGAATATCAGGCACACTAATATCAGTTGTACTTCCGTAATAACTGGATAGTTGT 5’
5’GCGAATAGAAAATATTAGTTATGGAAAGTTTTCTTC------AAAAGATTCAGCTCTGTTCATAAA 3’
3’CGCTTATCTTTTATAATCAATACCTTTCAAAAGAAG------TTTTCTAAGTCGAGACAAGTATTT 5’
5’TACTATTTCTTTTGTCGACTATAGTCTACATTCTAAACATCTAAGGCTTTTTTTTCAATCTTnnnn 3’
3’ATGATAAAGAAAACAGCTGATATCAGATGTAAGATTTGTAGATTCCGAAAAAAAAGTTAGAAnnnn 5’
+1
Met1
M.Esp1396I
Met1
C.Esp1396I
+1 –10
Pesp1396ICR
–10
Pesp1396IM
proximal distal
–35
Pesp1396IM
C-box esp1396IC M I 6 9 3 1 p s e R I 6 9 3 1 p s e
esp1396IC
Figure 1. Genetic organization of restriction–modiﬁcation system Esp1396I. The esp1396I genes with upstream C.Esp1396I binding sites are sche-
matically shown on the top. Arrows show the direction of transcription. Two esp1396I transcription units (M and CR) are separated by a region that
may contain a bidirectional transcription terminator (depicted as a hairpin). DNA sequences around transcription start points of the esp1396IM and
esp1396ICR promoters are expanded below (both DNA strands are shown). Beginnings of coding regions are indicated with colors that match those
at the top of the ﬁgure and esp1396IC and esp1396IM are highlighted in bold typeface and indicated as ‘Met
1’. The Pesp1396IM and Pesp1396ICR
start sites are indicated by red color and bold typeface, and leftward and rightward arrows below and above the sequence. Conserved promoter
elements are labeled and underlined. The esp1396ICR C-box is indicated by blue color and a black line above the sequence with distal and proximal
C.Esp1396I binding sites labeled. Two sets of inverted repeats are shown by convergent arrows. Sequences constituting the recently discovered
‘TATA’-based dyad are boxed. Sequences within one set of perfect inverted repeats in Pesp1396IM are similarly indicated and highlighted with
orange-colored font. An imperfect set of repeats in Pesp1396IM identiﬁed in ref. (8) is shown by inverted arrows above black-colored font. At the top
of the ﬁgure, the orientation of C.Esp1396I dimers at promoter-distal (subunits A, B) and promoter-proximal (subunits C, D) Pesp1396ICR binding
sites is shown (19).
Nucleic Acids Research, 2009,Vol.37, No. 10 3357should be located contains a GTGTGA sequence. Thus,
the similarity of the esp1396ICR promoter (Pesp1396ICR)
elements to consensus elements is low, suggesting that
basal activity level of this promoter is also low. Primer
extension reactions with a primer designed to reveal
transcription from the Esp1396I methylase promoter
(Pesp1396IM) revealed a single product whose 50-end cor-
responded to a thymidine located 20-bp upstream of the
initiating ATG of esp1396IM (Figure 2A, right panel).
This residue is preceded by an appropriately positioned
TAGAAT sequence that is highly similar to the consensus
 10 promoter element sequence TATAAT; at an appro-
priate distance upstream, a TTGAAA sequence that is
similar to the  35 promoter consensus element sequence
TTGACA is located (Figure 1).
To show C.Esp1396I-dependence of esp1396I pro-
moters, fragments containing Pesp1396ICR or
Pesp1396IM with corresponding ﬂanking sequences were
cloned in front of promoterless galK gene of the pFD51
plasmid. Cells containing the resultant Pesp1396ICR::galK
fusion plasmid pEspRes formed white colonies on
McConkey agar (Figure 2B, top, plate sector 1) and no
primer extension product corresponding to Pesp1396ICR
transcript could be detected (Figure 2B, bottom, lane 1).
However, cells harboring pEspRes and a compatible plas-
mid producing C.Esp1396I formed colonies of deep red
color (Figure 2B, top, plate sector 2) and robust primer
extension product corresponding to Pesp1396ICR tran-
script was detected (Figure 2B, bottom, lane 2). Thus,
C.Esp1396I is required for Pesp1396ICR activity.
+ Esp1396I
–2 –4 –6
phage l dilution
– Esp1396I
1     2 G    A    T    C G    A    T    C 1     2
A
BP esp1396ICR
2 1
Pesp1396IM
2 1
G    A    T    C
C
G    A    T    C
Figure 2. Expression of the esp1396I genes in vivo.( A) The horizontal lines on the left panel show overnight 378C growth of E. coli cells harboring a
plasmid containing the entire Esp1396I system of without such a plasmid on an LB agar plate. Cells were spotted with indicated dilutions of -vir
phage lysate. Two panels on the right show the results of primer extension analysis carried out with RNA puriﬁed from cells harboring a plasmid
containing the entire Esp1396I system with a primer speciﬁc for esp1396ICR transcription unit (middle panel) or with a esp1396IM-speciﬁc primer
(right panel). Primer extension products are indicated by arrows. (B and C) Top panels shows the results of overnight 378C growth of E. coli cells
harboring esp1396ICR (B) or esp1396IM (C) promoters fused to promotorless galK in the absence (1) or presence (2) or a compatible plasmid
expressing C.Esp1396I on McConkey agar plates. Bottom panels show the results of primer extension analysis of RNA puriﬁed from cells shown at
the top with a galK speciﬁc primer.
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purple colonies on McConkey plates (Figure 2C, top,
plate sector 1) and robust primer extension product corre-
sponding to a transcript initiated from the Pesp1396IM
start site as well as two positions immediately upstream
and downstream of this point were observed (Figure 2C,
bottom, lane 1). In contrast, cells harboring pEspMet and
a compatible plasmid producing C.Esp1396I formed white
colonies (Figure 2C, top, plate sector 2) and no primer
extension product corresponding to Pesp1396IM tran-
script could be detected (Figure 2C, bottom, lane 2).
We therefore conclude that C.Esp1396I represses tran-
scription from Pesp1396IM.
In vitro analysis of C.Esp1396I effects on transcription
from Esp1396I promoters
To determine the eﬀect of C.Esp1396I on the for-
mation of transcription-competent open complexes
on Pesp1396ICR, KMnO4 probing was performed.
The addition of the RNAP s
70 holoenzyme alone did
not lead to appearance of KMnO4-sensitive thymines in
the  10 element of Pesp1396ICR (Figure 3A, lane 3).
However, the addition of 8-fold excess (over DNA) of
C.Esp1396I and RNAP led to the appearance of robust
KMnO4-sensitivity of thymines in the  10 element of
Pesp1396ICR and around the transcription start point
(Figure 3A, lane 4). The results thus indicate that
C.Esp1396I promotes open complex formation on
Pesp1396ICR. In vitro transcription experiments revealed
very little transcription from Pesp1396ICR in the absence
of C.Esp1396I (Figure 3B, lane 1). The addition of
increasing concentrations of C.Esp1396I strongly stimu-
lated transcription initially, while further increase in the
amount of C.Esp1396I led to gradual decrease in tran-
scription (the latter eﬀect was not strongly pronounced).
Recently, a structure of C.Esp1396I bound to a binding
site located upstream of Pesp1396ICR was determined
in one of our laboratories (19). The structure revealed
two C.Esp1396I dimers that interacted with each other
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Figure 3. In vitro transcription from esp1396I promoters. (A) Escherichia coli RNAP s
70 holoenzyme (100nM) was combined with DNA fragments
containing 8nM Pesp1396ICR (A–C)o rPesp1396IM (D and E) in the presence, where indicated, of C.Esp1396I, whose concentrations ranged 0 to
500nM. In (D), a component indicated by red color was added to DNA ﬁrst, following an incubation long enough to allow complex formation and
subsequent addition of component indicated by black color. In (A and D), complexes were probed with KMnO4. On the left of these panels, the
sequence of the relevant portion of each promoter is mapped on the A+G sequencing marker lane. In (B and E), a single-round transcription
reaction was performed. In (C), abortive initiation reaction was performed using RNAP holoenzymes reconstituted with indicated s factors.
Reaction products were separated by denaturing gel electrophoreses and revealed using a Phosphorimager.
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distal (with respect to Pesp1396ICR transcription start
site) and Arg35 of the dimer bound to the proximal site.
Based on molecular modeling, it has been proposed that
the dimer bound to the distal site can activate transcrip-
tion through a protein–protein interaction between Glu25
and Arg588 of the RNAP s
70 subunit (19). To test this
hypothesis, we prepared recombinant s
70 subunit contain-
ing an alanine at position 588, and tested the ability of
RNAP containing such subunit to transcribe from
Pesp1396ICR in the presence or in the absence of
C.Esp1396I. The results, presented in Figure 3C, demon-
strate that RNAP holoenzyme containing mutant s
70 did
not respond to C.Esp1396I, conﬁrming the idea that
Arg588 is required for transcription activation by
C.Esp1396I.
KMnO4 probing showed robust open complex
formation on Pesp1396IM in the presence of RNAP
s
70 holoenzyme (Figure 3D, lane 3). The addition of
increasing concentrations of C.Esp1396I to preformed
Pesp1396IM open complexes caused only a slight decrease
in KMnO4 sensitivity (Figure 3D, lanes 7–9), indicating
that C.Esp1396I is relatively ineﬀective in dislodging
Pesp1396IM open complexes. In contrast, bound
C.Esp1396I eﬀectively inhibited promoter complex forma-
tion in a concentration-dependent manner (Figure 3D,
lanes 4–6). We therefore conclude that RNAP open com-
plex formation and C.Esp1396I binding to Pesp1396IM
are mutually exclusive. This conclusion is supported by
the results of electrophoretic mobility shift (EMSA)
experiments that revealed that RNAP is unable to
bind to Pesp1396IM DNA in the presence of bound
C.Esp1396I (data not shown). Transcription assays also
showed that C.Esp1396I abolished transcription from
Pesp1396IM when added before (Figure 3E), but not
after (data not shown) RNAP.
In vitro analysis of C.Esp1396I interaction with its
binding sites
Sedimentation equilibrium analytical ultracentrifugation
(AUC) experiments were carried out to conﬁrm the
dimeric status of C.Esp1396I and to obtain the Kd
for dimerisation (Supplementary Figure 1). An Mr of
17920Da was obtained, which compares well with the
theoretical Mr of an C.Esp1396I dimer (18450Da).
Analysis of the data with a monomer–dimer equilibrium
model gave a dimerization constant (Kd)o f 0.6mM,
4-fold lower than that observed for C.AhdI (14), indicat-
ing that the C.Esp1396I dimer is signiﬁcantly more stable.
The nature of complexes formed at each esp1396I pro-
moter was determined in sedimentation-velocity AUC
experiments using hex-labeled 35-bp esp1396I DNA frag-
ments containing C.Esp1396I binding sites (Figure 4).
With the Pesp1396ICR fragment at a protein:DNA ratio
of 4:1, a single species with sedimentation coeﬃcient of
3.9S predominated. Using the frictional ratio derived
from the ﬁt, a molecular weight of 60kDa was obtained,
corresponding to a tetrameric complex with two
C.Esp1396I dimers bound to DNA (Supplementary
Table 1). At a protein:DNA ratio of 2:1, both the free
DNA (2.7S) and the tetrameric complex (3.9S) were
observed but no C.Esp1396I dimer–DNA complexes
were discernible, indicating the high cooperativity of
binding to Pesp1396ICR. In the case of the Pesp1396IM
fragment, which contained the two putative C.Esp1396I
binding sites originally postulated (8), identical plots were
observed for both 4:1 and 2:1 protein:DNA ratios, with a
single species sedimenting at 3.3S. The derived molecular
weight (40kDa) corresponds to one C.Esp1396I dimer
bound to the DNA. Thus, only one of the two postulated
C-protein binding sites is occupied at the methylase pro-
moter, even in the presence of excess protein. Moreover,
the higher aﬃnity of C.Esp1396I for the Pesp1396IM site,
compared to Pesp1396ICR sites, is evident since the
former is fully bound at 2:1 protein/DNA ratio, whereas
the latter remains only partially bound at a 4:1 ratio.
DNase I footprinting of a Pesp1396ICR-containing
DNA fragment revealed little protection in the presence
of 4-fold molar excess of C.Esp1396I monomers over
DNA (Figure 5A, lane 2). However, in the presence of
8-fold excess of C.Esp1396I, complete protection of both
sets of inverted repeats as well as adjacent bases was
observed (Figure 5A, lane 3), indicating formation of a
tetrameric complex (19). The addition of C.Esp1396I to
the Pesp1396IM fragment resulted in complete protec-
tion of the entire inverted repeat and partial protection
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Figure 4. Sedimentation velocity analysis of C.Esp1396I–DNA complexes. The c(S) distribution plots for the C.Esp1386I-DNA complexes with
Pesp1396ICR (A) and Pesp1396IM (B) derived 35-bp DNA fragments are shown. Plots labeled blue, red and green, correspond to free DNA duplex,
a 2:1C.Esp1396I:DNA molar ratio, and a 4:1C.Esp1396I:DNA molar ratio, respectively. In all cases, the ﬁnal concentration of the hex-labeled DNA
duplex was 5mM.
3360 Nucleic Acids Research, 2009, Vol. 37,No. 10extending 5–6bp in both directions outside the repeat in
the presence of both 4-fold and 8-fold molar excess of
C.Esp1396I monomers over DNA (Figure 5B, lanes
2 and 3). The result thus conﬁrms that C.Esp1396I binds
Pesp1396IM as a dimer, in agreement with the AUC data,
and identiﬁes the location of the binding site at this
promoter.
To derive equilibrium binding constants of C.Esp1396I
interactions with its binding sites, we performed solution-
based ﬂuorescence polarization assays. Fluorescence
polarization does not involve steps that could potentially
perturb the binding equilibria being measured (such
as physical separation of free and bound species) and
therefore allows true equilibrium determinations of
macromolecular interactions (29,30). Promoter fragments
were labeled at the 50-end with ﬂuorescein and ﬂuores-
cence polarization of DNA fragments was measured as
a function of C.Esp1396I concentration (Figure 6A).
Equilibrium constants describing the binding of
C.Esp1396I were obtained by nonlinear regression analy-
sis and ﬁtting the data to a model involving binding of a
single dimer of C.Esp1396I to Pesp1396IM-containing
fragment and cooperative binding of two C.Esp1396I
dimers to Pesp1396ICR-containing fragment. While satis-
factory ﬁts of polarization data for both Pesp1396IM and
Pesp1396ICR sites could be obtained using either of these
models, only the speciﬁc models described above were
considered since they were consistent with data described
above. Also, the models were consistent with higher total
ﬂuorescence polarization changes observed with
Pesp1396ICR DNA indicating larger complexes formed
with this DNA (Figure 6A, compare panels on the left
and on the right).
Quantitative analysis was performed assuming that
C.Esp1396I exhibits monomer–dimer equilibrium with a
dissociation constant of 600nM (as determined by AUC,
above). With these assumptions, the aﬃnity of
C.Esp1396I for the single Pesp1396IM binding site
(Kd=0.3nM) was much higher then the aﬃnity for
either of the Pesp1396ICR binding sites (Kd’s of 6.9 and
322nM for the distal and proximal sites, respectively).
The signiﬁcantly weaker binding of C.Esp1396I to the
proximal site (OR) compared to the distal site (OL)i si n
agreement with the results of EMSA experiments (19).
The weaker binding of C.Esp1396I dimers to
Pesp1396ICR was partially compensated by high positive
cooperativity between the sites ( 200-fold enhancement of
binding aﬃnity to a given site when the other site is occu-
pied with the protein). Nevertheless, the net outcome is
that Pesp1396IM is a better binder than Pesp1396ICR.
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Nucleic Acids Research, 2009,Vol.37, No. 10 3361This is best illustrated by competition experiments
designed to determine how C.Esp1396I partitions between
the Pesp1396IM and Pesp1396ICR sites. To this end, ﬂuo-
rescence polarization assays were performed at conditions
of competition between Pesp1396IM and Pesp1396ICR
fragments. The results, presented in Figure 6B, show
that unlabeled Pesp1396IM was an eﬀective competitor
of the binding C.Esp1396I to labeled Pesp1396ICR (left
panel), whereas unlabeled Pesp1396ICR had no eﬀect on
the binding of C.Esp1396I to labeled Pesp1396IM (right
panel). We therefore conclude that given a choice,
C.Esp1396I binds to Pesp1396IM ﬁrst, and only then
occupies the Pesp1396ICR binding sites.
Mutational analysis of C.Esp1396I binding sites
Structural analysis of a complex of two C.Esp1396I
dimers bound to the 35bp Pesp1396ICR site revealed,
surprisingly, that the principal interactions that each
dimer makes with its binding site are not determined
by a pseudo 2-fold axis that separates two sets of
inverted tetranucleotide repeats in the idealized consensus
GACTnnnAGTCnnnGACTnnnAGTC (19). Rather, they
are related by a 2-fold axis that is oﬀset by half a base pair,
which leads to a loss of a pseudo-dyad between the
inverted tetranucleotide repeats but results in perfectly
symmetrical TATA sequences located between each pair
of repeats (19). In addition, TG and CA dinucleotides at
the outside of the double site also become symmetrical
with respect to this axis. In the structure, each
C.Esp1396I dimer makes speciﬁc interactions with inter-
nal TATA spacers and outer TG/CA dinucleotides. The
dyad axis of each dimer in the complex is located between
the A and the T of the TATA spacer. For the purposes of
the discussion presented below, it is convenient to use the
notation introduced by McGeehan et al. (19), where
C.Esp1396I subunits A/B comprise the dimer that binds
the distal site, while the C/D dimer binds to the proximal
site (Figure 1). It is also important to note that in the
crystal structure, the Arg35 side-chains of the central sub-
units B and C each appear in dual conformations
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Figure 6. Interaction of C. Esp1396I with esp1396I binding sites measured by ﬂuorescence polarization. (A) DNA binding of C.Esp1396I analyzed by
ﬂuorescence polarization of ﬂuorescein-labeled Pesp1396ICR (left) and Pesp1396IM (right) DNA fragments. Solid lines show best ﬁts of the models
to experimental data. The best ﬁt parameters for Pesp1936ICR were Kp=322nM, Kd=6.9nM and cooperativity 219. The best ﬁt equilibrium
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3362 Nucleic Acids Research, 2009, Vol. 37,No. 10(occupancy=0.5) so that they can interact both with the
DNA bases in the centre of the sequence, and with the
Glu25 side-chains of adjacent subunits.
Analysis of the esp1396ICR promoter
To investigate further the interactions that contribute to
site recognition by C.Esp1396I, EMSA experiments were
performed with double-stranded DNA fragments carrying
mutations in a 33bp Pesp1396ICR fragment containing
both C.Esp1396I binding sites. We speciﬁcally sought to
determine the importance of ‘outer’ dinucleotides TG and
CA in positions 1, 2 and 32, 33, respectively, and what the
consequences would be of introducing the ‘missing’ inter-
nal symmetry-related dinucleotide on C.Esp1396I binding
to each site. Based on structural analysis, we expected that
the former substitutions would decrease the binding, while
introduction of symmetry related dinucleotides between
the individual binding sites would increase the binding
of a C.Esp1396I dimer to a site, while decreasing the coop-
erativity of the binding. We also introduced double
substitutions in the tetranucleotide repeats, to check
their importance for the binding, despite the apparent
lack of visible speciﬁc interaction and the fact that these
repeats are not symmetry related in the complex. The
results are presented in Figure 7A. For the wild-type
fragment, a shifted band corresponding to a bound
C.Esp1396I tetramer was observed, in agreement with
the analyses above. A minor band corresponding to a
dimer was seen only transiently at low concentrations of
C.Esp1396I.
Substitution of the symmetry-related TG dinucleotide
for GT at positions 1, 2 strongly decreased the amounts
of complexes formed; however, all complexes detected cor-
responded to the tetrameric complex, i.e. two C.Esp1396I
dimers bound to DNA. The observed decrease in binding
eﬃciency is consistent with the signiﬁcance of the TG
dinucleotide for C.Esp1396I binding. Substitution of the
symmetry-related CA dinucleotide for AC at positions 32,
33 abolished formation of the tetrameric complex; instead,
a dimeric complex was formed. We attribute this to the
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Figure 7. Analysis of C.Esp1396I complexes with wild-type and mutant esp1396I promoters using electrophoretic mobility shift assay. (A) The
sequences of the wild-type esp1396ICR C-boxes with symmetrical elements highlighted is presented at the top of the ﬁgure. Numbers below refer to
positions of nucleotides in the C-box. The gels below show the results of native gel separation of complexes formed in the absence or in the presence
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Nucleic Acids Research, 2009,Vol.37, No. 10 3363fact that the proximal site is intrinsically weak (19) and
that further reduction in binding aﬃnity by substitution of
the CA dinucleotide leads to binding only at the distal site.
A fragment containing a CA dinucleotide at positions
17 and 18 (symmetry related to the TG dinucleotide at
positions 1, 2) did not form a low-mobility (tetrameric)
complex, instead forming a dimeric complex. We suggest
the following explanation. Introduction of the CA dinu-
cleotide should favor the interaction of Arg35 of subunit B
with these bases, rather than with Glu25 of subunit C
in the adjacent dimer. As a result, cooperativity (i.e.
enhancement of the binding of the second dimer to the
proximal site) is reduced, leading to the occupation of
the distal site only.
A fragment containing a TG dinucleotide at positions
16 and 17 (symmetry related to CA at positions 32, 33) did
not form speciﬁc complexes with C.Esp1396I. Detailed
examination of the structure of the complex provides a
possible explanation for the absence of binding to the
mutant DNA fragment. Although this mutation might
be expected to enhance binding of the proximal dimer
through the interaction of Arg35 of subunit C with the
newly introduced TG, at the same time it would eliminate
the possible interaction of Arg35 of subunit B with the
highly conserved central GT, and thus weaken the binding
of the A/B dimer to the distal site. Since a protein dimer
has to bind to the distal site before occupying the proximal
site, almost no DNA binding is observed.
For a fragment carrying a substitution in the tetranu-
cleotide repeat in the distal site (positions 5, 6), only a
band whose mobility corresponded to the expected mobil-
ity of a complex containing a single C.Esp1396I dimer was
observed. For a fragment carrying a substitution in
the tetranucleotide repeat in the proximal site (positions
27, 28), we observe a minor tetrameric complex band,
together with a large diﬀuse band of higher mobility
than that of the dimeric complex. A fragment carrying
substitutions in tetranucleotide repeats in both
C.Esp1396I binding sites did not form complexes with
C.Esp1396I. Thus, the sequence of tetranucleotide repeats
clearly contributes to DNA binding aﬃnity. Further
understanding of the precise interactions at these sites
will require higher resolution structural data than those
currently available.
Analysis of the esp1396IM promoter
The sequence of the single C.Esp1396I binding site within
Pesp1396IM is more symmetrical than either of the
two Pesp1396ICR binding sites, with only two base pairs
(positions 4 and 15) not conforming to palindromic sym-
metry around the dyad axis located within the central
TATA sequence. The symmetrical base pairs include the
outer TG/CA dinucleotides that are seen to interact
strongly with Arg35 in the crystal structure of the tetra-
meric complex. The importance of the TATA-centered
symmetry could explain the strong preference of
C.Esp1396I for the M binding site compared to either
the distal or proximal CR binding sites. To test this
idea, we separately mutated the TG dinucleotide in posi-
tions 1, 2 and the equivalent CA dinucleotide in positions
17 and 18 of the Pesp1396IM binding site. It was
conﬁrmed that these outer dinucleotides make a major
contribution to DNA sequence recognition, as in both
cases the binding was abolished (Figure 7B).
Mutation of the central TATA (positions 10, 11) gave
an unexpected result: although binding was signiﬁcantly
weakened, the mobility of the complex was lower than
that for the wild type sequence. This probably represents
a conformational change, as there is only one binding
site on this 18-bp sequence. Since DNA bending results
in enhanced gel mobility of C-protein complexes (19,31),
one plausible explanation of this result would be that
changing TATA to TAGT disrupts the alternating
purine–pyrimidine sequence and thus reduces DNA bend-
ing in the complex, giving rise to a lower mobility
complex.
Next, we mutated two base pairs (positions 6 and 7)
within the GAC/GTC sequence that are also related by
symmetry around the TATA dyad (but were originally
postulated to conform to the GACT/AGTC tetranucleo-
tide repeat). This mutation completely abolishes DNA
binding (Figure 7B), showing that recognition of these
sequences is also important.
Comparing the sequence of Pesp1396IM with the
previously proposed GACT....AGTC symmetry,
Cesnaviciene et al. (8) suggested that this sequence aligned
better to the consensus if an insertion was made in the
‘‘spacer’’ region. We therefore introduced an additional
base (T) into the spacer region to see if DNA binding
was enhanced. On the contrary, however, DNA binding
to the mutant fragment (labeled ‘wt+T’ on Figure 7B)
was weakened when the TATA symmetry was perturbed
by this insertion (Figure 7B), despite the presence of
GACT/AGTC palindromes on either side of the TAT
spacer in the mutated sequence.
DISCUSSION
In this work, we map Esp1396I promoters and demon-
strate that transcription of both the restriction endonu-
clease and methyltransferase genes is controlled by
interdependent regulatory loops governed by the
C.Esp1396I protein. In the absence of C.Esp1396I, i.e. in
a situation encountered when the Esp1396I system genes
enter a naı¨ve host, the esp1396IM promoter is highly
active, leading to production of the Esp1396I methyltrans-
ferase and methylation of Esp1396I sites in the host
genome. Basal transcription from Pesp1396ICR results
in gradual accumulation of C.Esp1396I, which upon
dimerization binds to a single site in Pesp1396IM, prevent-
ing further transcription from this promoter. Further
accumulation of C.Esp1396I results in activation and
then gradual repression of Pesp1396ICR. The interaction
of C.Esp1396I with the binding sites in Pesp1396ICR
is highly cooperative and we were unable to detect an
‘activating’ complex of C.Esp1396I dimer with the distal
binding site. Instead, a ‘repressing’ complex of C.Esp1396I
tetramer bound to both binding sites was detected. A
similar situation was encountered during the analysis of
ahdICR promoter regulation by C.AhdI (17). There, we
3364 Nucleic Acids Research, 2009, Vol. 37,No. 10showed that transcription activation by C.AhdI can be
quantitatively explained by a model in which RNAP out-
competes the C.AhdI dimer from the promoter–proximal
binding site due to favorable interactions between the
C.AhdI dimer bound at promoter–distal site (OL) and
RNAP. The same mechanism of transcription activation
is likely operational in the case of Pesp1396ICR. In vitro,
such mechanism of activation is quite ineﬃcient, since
only a small fraction of templates becomes transcription-
ally active even when transcription reaches its maximal
levels. Indeed, even at conditions when maximal amounts
of open promoter complexes at Pesp1396ICR were formed
in vitro (as judged by KMnO4 probing) no DNase I foot-
print of RNAP could be detected (data not shown). The
apparent ineﬃciency of C.Esp1396I activation is likely to
be biologically signiﬁcant as it decreases the steady-state
level of expression of restriction endonuclease, a highly
toxic protein. This represents a ‘trade-oﬀ’ between opti-
mizing the eﬃciency of transcription of the endonuclease
gene, and ensuring complete shut-down of the gene once
suﬃcient enzyme has been synthesized, the latter being
more critical.
Unlike most other R-M systems studied, unregulated
expression of Esp1396I methylase from its own promoter
is toxic to the cell. The eﬀect must be unrelated to speciﬁc
methylation activity of the enzyme, since all recognition
sites in the host genome must be methylated to prevent
restriction. The preferential binding of C.Esp1396I to
the Pesp1396IM site decreases the level of esp1396IM
expression even before Pesp1396ICR is fully turned on.
Presumably evolution has ﬁne-tuned the binding aﬃnities
of the operators (and in the case of the C/R promoter, the
protein-protein interactions responsible for cooperativity)
to optimize the time-dependence and steady-state activity
of both methylation and restriction in a coordinated
manner. Bioinformatic analysis reveals that several other
C-protein dependent systems are organized similarly to
Esp1396I (8, V. Sorokin, M. Gelfand, and K.S., unpub-
lished data). In all cases, palindromic sites that likely func-
tion as C-protein binding sites are present in front of both
the M and CR genes.
The relative binding aﬃnities of C.Esp1396I for the
three operator sites involved in this regulatory control
circuit are markedly diﬀerent, reﬂecting their diﬀering bio-
logical functions. The highest aﬃnity binding site for
C.Esp1396I is the operator site OM controlling repression
of the methyltransferase, the binding aﬃnity of which is
 20-fold higher than that of the distal operator (OL) that
activates transcription of the C/R promoter. The distal
operator in turn has  50-fold higher aﬃnity than the
proximal binding site (OR) that governs repression of the
C and R genes. Nevertheless, the OR site is occupied soon
after the OL site, due to the high degree of cooperativity
( 200) that arises, at least in part, from the interaction of
Arg35 and Glu25 at the interface of adjacent dimers (19).
This solution (rather than having a high intrinsic aﬃnity
for OR) ensures that transcription of the C/R genes
occurs at low levels of controller protein, whilst still allow-
ing complete repression at higher concentrations of the
protein.
All three operators (Figure 8) have in common the cen-
tral TATA sequence that allows compression of the minor
groove of the DNA, forcing DNA bending at the centre of
the dimer binding site in the complex (19). The strongest
binding site, OM, in addition contains the symmetry
related TG and CA dinucleotide sequences that interact
strongly with Arg35 of the controller protein (19), whereas
OL and OR have just one of these dinucleotides (clearly,
both TG and CA are not possible simultaneously as the
binding sites overlap in this region). It is notable that the
sequence of the highest aﬃnity site, OM, is almost per-
fectly palindromic, with 16 of the 18 bases being related
by dyad symmetry (Figure 8). Indeed, at least two of the
three operators have identical bases at these 16 sites, of
which 7 consecutive bases (TATAGTC) are identical in all
three operators.
Our mutational studies show the importance of the
interactions with the TATA and TG/CA bases for com-
plex formation, in agreement with the protein–DNA inter-
actions seen in the crystal structure of the complex (19).
In addition, however, it is clear that mutations within the
so-called ‘tetranucleotide repeats’ also diminish binding of
C.Esp1396I, as has also recently been shown for C.PvuII
(32). Interactions of amino acids with bases in this region
cannot be clearly identiﬁed in the crystal structure at this
resolution, but are likely to be present, since this is where
the recognition helix (helix 3) inserts into the major
groove. Nevertheless, we have shown that insertion of
an additional base into the TATA sequence to make the
GACT/AGCT sequences symmetric around a TAT spacer
reduces DNA binding. Clearly the DNA sequence and
structure recognition mechanisms of controller proteins
are yet to be fully understood. High-resolution crystallo-
graphic studies with all three operator sites are in progress
to identify the precise intermolecular interactions in
each case.
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